Vivos Therapeutics, Inc. financial data

Symbol
VVOS on Nasdaq
Location
Littleton, CO
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 100% % 28%
Debt-to-equity 302% % 17%
Return On Equity -351% % -4.8%
Return On Assets -87% % 6.6%
Operating Margin -94% % -10%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,504,807 shares 55%
Common Stock, Shares, Outstanding 8,266,877 shares 73%
Entity Public Float $7,400,000 USD -52%
Common Stock, Value, Issued $1,000 USD
Weighted Average Number of Shares Outstanding, Basic 10,963,590 shares 66%
Weighted Average Number of Shares Outstanding, Diluted 10,963,590 shares 66%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $17,317,000 USD 19%
Research and Development Expense $100,000 USD -50%
Selling and Marketing Expense $1,431,000 USD -26%
General and Administrative Expense $23,533,000 USD 24%
Operating Income (Loss) $16,322,000 USD -31%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $17,104,000 USD -36%
Net Income (Loss) Attributable to Parent $17,104,000 USD -36%
Earnings Per Share, Basic -1 USD/shares 81%
Earnings Per Share, Diluted -1 USD/shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,087,000 USD -51%
Accounts Receivable, after Allowance for Credit Loss, Current $2,134,000 USD 370%
Assets, Current $5,786,000 USD -22%
Property, Plant and Equipment, Net $5,642,000 USD 70%
Operating Lease, Right-of-Use Asset $3,383,000 USD 200%
Intangible Assets, Net (Excluding Goodwill) $2,172,000 USD 467%
Goodwill $8,450,000 USD 197%
Assets $25,644,000 USD 67%
Accounts Payable, Current $2,103,000 USD 96%
Accrued Liabilities, Current $2,682,000 USD 31%
Contract with Customer, Liability, Current $537,000 USD -59%
Liabilities, Current $7,437,000 USD 45%
Long-term Debt and Lease Obligation $1,200,000 USD 0%
Contract with Customer, Liability, Noncurrent $1,000 USD -99%
Operating Lease, Liability, Noncurrent $2,866,000 USD 147%
Other Liabilities, Noncurrent $1,400,000 USD
Liabilities $23,112,000 USD 201%
Retained Earnings (Accumulated Deficit) $118,464,000 USD -17%
Stockholders' Equity Attributable to Parent $2,532,000 USD -67%
Liabilities and Equity $25,644,000 USD 67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,796,000 USD -51%
Net Cash Provided by (Used in) Financing Activities $3,635,000 USD -51%
Net Cash Provided by (Used in) Investing Activities $122,000 USD 19%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 8,266,877 shares 73%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,918,000 USD -505%
Deferred Tax Assets, Valuation Allowance $21,522,000 USD 11%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $21,777,000 USD 11%
Operating Lease, Liability $1,512,000 USD -24%
Depreciation $1,200,000 USD 140%
Payments to Acquire Property, Plant, and Equipment $122,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid $1,725,000 USD -27%
Property, Plant and Equipment, Gross $8,673,000 USD 44%
Operating Lease, Liability, Current $734,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Two $507,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year One $585,000 USD -5.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $213,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Three $493,000 USD -2.8%
Deferred Tax Assets, Operating Loss Carryforwards $19,872,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $133,000 USD -73%
Operating Lease, Payments $153,000 USD
Additional Paid in Capital $120,995,000 USD 11%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $100,000 USD 0%
Depreciation, Depletion and Amortization $177,000 USD 21%
Deferred Tax Assets, Net of Valuation Allowance $255,000 USD -25%
Share-based Payment Arrangement, Expense $500,000 USD -50%
Interest Expense $500,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%